Gregor Kevrekian

Gregor brings significant expertise in healthcare, investing and computational methods. He previously served as VP, Head of Corporate Development at CVS Health, a Fortune 5 company. At CVS, Gregor led $25B+ in transactions, including acquisitions of Oak Street Health for $10B and Signify Health for $8B. Prior to that, Gregor led Aetna’s corporate venture fund, focusing on tech-enabled healthcare services. He also served on the deal team during CVS Health’s $78B acquisition of Aetna. 

Prior to joining Aetna, Gregor worked in M&A and venture capital at United Technologies. He began his career as an aerospace engineer at Pratt & Whitney, later moving into supply chain development, budget management and finance. He holds an MBA from the University of Connecticut, and a BS and MS in Mechanical Engineering from Worcester Polytechnic Institute, where he focused his graduate studies on computational methods.